Report Overview

The US Neuropathic Pain market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Neuropathic pain caused by damage or disease affecting the somatosensory nervous structure. The neuropathic pain may be associated with abnormal sensations known as dysesthesia pain. Neuropathic pain can be contrasted to nociceptive pain, which occurs when someone experiences an acute injury, such as smashing a finger with a hammer or knocking a toe when walking barefoot. This type of pain is typically short-lived and generally quite responsive to common pain medications indifference to neuropathic pain



Market Drivers

High prevalence of cancer is expected to propel growth of neuropathic pain market over the forecast period. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the US

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the US Census Bureau, the US geriatric population is expected to reach 77 million by 2034